日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A Rare Discovery of Neuroendocrine Tumor: Cardiac Mass

罕见的神经内分泌肿瘤发现:心脏肿块

Shrestha, Anish K; Devkota, Anirudra; Chen, Terina S; Mohebtash, Mahsa

HALT-D: a randomized open-label phase II study of crofelemer for the prevention of chemotherapy-induced diarrhea in patients with HER2-positive breast cancer receiving trastuzumab, pertuzumab, and a taxane

HALT-D:一项随机、开放标签的 II 期研究,旨在评估 crofelemer 用于预防接受曲妥珠单抗、帕妥珠单抗和紫杉烷类药物治疗的 HER2 阳性乳腺癌患者化疗引起的腹泻的疗效。

Pohlmann, Paula R; Graham, Deena; Wu, Tianmin; Ottaviano, Yvonne; Mohebtash, Mahsa; Kurian, Shweta; McNamara, Donna; Lynce, Filipa; Warren, Robert; Dilawari, Asma; Rao, Suman; Mainor, Candace; Swanson, Nicole; Tan, Ming; Isaacs, Claudine; Swain, Sandra M

Hematologic safety of palbociclib in combination with endocrine therapy in patients with benign ethnic neutropenia and advanced breast cancer

帕博西尼联合内分泌治疗治疗良性种族性中性粒细胞减少症和晚期乳腺癌患者的血液学安全性

Lynce, Filipa; Blackburn, Matthew J; Zhuo, Rebecca; Gallagher, Christopher; Hahn, Olwen M; Abu-Khalaf, Maysa; Mohebtash, Mahsa; Wu, Tianmin; Pohlmann, Paula R; Dilawari, Asma; Tiwari, Shruti R; Chitalia, Ami; Warren, Robert; Tan, Ming; Shajahan-Haq, Ayesha N; Isaacs, Claudine

PALINA: A phase II safety study of palbociclib in combination with letrozole or fulvestrant in African American women with hormone receptor positive HER2 negative advanced breast cancer

PALINA:一项针对激素受体阳性、HER2阴性晚期乳腺癌非裔美国女性的帕博西尼联合来曲唑或氟维司群的II期安全性研究

Lynce, Filipa; Saleh, Mervat; Shajahan-Haq, Ayesha; Gallagher, Christopher; Dilawari, Asma; Hahn, Olwen; Abu-Khalaf, Maysa; Cai, Ling; Pohlmann, Paula; Mohebtash, Mahsa; Kamugisha, Lois; Isaacs, Claudine

Video intervention increases participation of black breast cancer patients in therapeutic trials

视频干预提高了黑人乳腺癌患者参与治疗试验的积极性

Robinson, Brandi N; Newman, Antoinette F; Tefera, Eshetu; Herbolsheimer, Pia; Nunes, Raquel; Gallagher, Christopher; Randolph-Jackson, Pamela; Omogbehin, Adedamola; Dilawari, Asma; Pohlmann, Paula R; Mohebtash, Mahsa; Lee, Young; Ottaviano, Yvonne; Mohapatra, Avani; Lynce, Filipa; Brown, Richard; Mete, Mihriye; Swain, Sandra M

Docetaxel Alone or in Combination With a Therapeutic Cancer Vaccine (PANVAC) in Patients With Metastatic Breast Cancer: A Randomized Clinical Trial

多西他赛单药治疗或联合治疗性癌症疫苗(PANVAC)治疗转移性乳腺癌患者:一项随机临床试验

Heery, Christopher R; Ibrahim, Nuhad K; Arlen, Philip M; Mohebtash, Mahsa; Murray, James L; Koenig, Kimberly; Madan, Ravi A; McMahon, Sheri; Marté, Jennifer L; Steinberg, Seth M; Donahue, Renee N; Grenga, Italia; Jochems, Caroline; Farsaci, Benedetto; Folio, Les R; Schlom, Jeffrey; Gulley, James L

A pilot study of MUC-1/CEA/TRICOM poxviral-based vaccine in patients with metastatic breast and ovarian cancer

针对转移性乳腺癌和卵巢癌患者的 MUC-1/CEA/TRICOM 痘病毒疫苗的初步研究

Mahsa Mohebtash, Kwong-Yok Tsang, Ravi A Madan, Ngar-Yee Huen, Diane J Poole, Caroline Jochems, Jacquin Jones, Theresa Ferrara, Christopher R Heery, Philip M Arlen, Seth M Steinberg, Mary Pazdur, Myrna Rauckhorst, Elizabeth C Jones, William L Dahut, Jeffrey Schlom, James L Gulley

Therapeutic vaccines in metastatic castration-resistant prostate cancer: principles in clinical trial design

转移性去势抵抗性前列腺癌的治疗性疫苗:临床试验设计原则

Madan, Ravi A; Mohebtash, Mahsa; Schlom, Jeffrey; Gulley, James L

Promising novel immunotherapies and combinations for prostate cancer

前列腺癌的有前景的新型免疫疗法和联合疗法

Arlen, Philip M; Mohebtash, Mahsa; Madan, Ravi A; Gulley, James L